Topic Cardiovascular
Profession
All
Nurse
Pharmacist
Pharmacy Technician
Topic
All
arrhythmia
Billing
Cardiology
Cardiovascular
Cardiovascular(hypertension
Compounding
Compounding (sterile/non-sterile compounding)
Controlled Substance Monitoring / Drug Diversion
COVID-19
COVID-19/Coronavirus
Cultural Competency
Diabetes
Disease State Mgt / Drug Therapy
Drug Overview
Endocrine
Endocrine (diabetes
FL Approved
Gastroenterology
Gender-Specific Health
General Practice
Geriatrics
HIV / AIDS
Human Trafficking
Immunizations
Law
LGBTQ
lipids)
Medical Marijuana
Medication Errors
Men's Health
metabolic disorders)
Miscellaneous
Neurological
Nutrition
OTC/herbal/natural
OTC/herbal/natural remedies
Pain
Pain Management
Patient Safety
Pediatrics
Pediatrics / Adolescents
Pharmacy Management
Poison Prevention
Psychiatric
Reimbursement
Respiratory
Spanish Language
stroke
The freeCE Weekly Dose
Women's Health
Past and Future Events
All
Only Past Events
Only Future Events
september
Event Details
The guideline governing the management of blood cholesterol to reduce cardiovascular risk was revised at the end of 2018. At that time, several critical changes were made to the guideline,
Event Details
The guideline governing the management of blood cholesterol to reduce cardiovascular risk was revised at the end of 2018. At that time, several critical changes were made to the guideline, including the identification of high-risk and very high-risk factors, restructuring of patient groups in which to consider drug therapy, revised therapeutic targets, and incorporation of select non-statin drugs to the clinical armamentarium. Furthermore, two additional non-statin products have come to market since the guideline’s publication. It is imperative to disseminate these updates to healthcare practitioners, so that they can provide evidence-based, patient-centered care as members of an interdisciplinary team.
more
Time
(Friday) 10:30 am - 11:30 am(GMT-04:00) View in my time
19sep2:00 pm3:00 pmHyperlipidemia Guideline Updates: How Low Do We Go?
Event Details
Hyperlipidemia is a common disease state encountered in the clinical setting and guidelines have been recently updated to discuss the role of therapies, therapeutic goals, and other clinical considerations. Using
Event Details
Hyperlipidemia is a common disease state encountered in the clinical setting and guidelines have been recently updated to discuss the role of therapies, therapeutic goals, and other clinical considerations. Using a review of primary medications utilized, including an update of guidelines and key recommendations, this presentation will assist healthcare providers in feeling comfortable with initiating, monitoring, and counseling on these therapies.
Time
(Tuesday) 2:00 pm - 3:00 pm(GMT-04:00) View in my time
november
30nov11:30 am12:30 pmHyperlipidemia Guideline Updates: How Low Do We Go?
Event Details
Hyperlipidemia is a common disease state encountered in the clinical setting and guidelines have been recently updated to discuss the role of therapies, therapeutic goals, and other clinical considerations. Using
Event Details
Hyperlipidemia is a common disease state encountered in the clinical setting and guidelines have been recently updated to discuss the role of therapies, therapeutic goals, and other clinical considerations. Using a review of primary medications utilized, including an update of guidelines and key recommendations, this presentation will assist healthcare providers in feeling comfortable with initiating, monitoring, and counseling on these therapies.
Time
(Thursday) 11:30 am - 12:30 pm(GMT-05:00) View in my time